Stockfun1 Wednesday, 07/01/20 01:10:11 AM Re: dhbuzz post# 2484 Post # of 2526 What’s your thoughts on the path forward. IMHO, because this is still passing the MDA with FDA and still will be used heavily by physicians for FX. Even those without 90% methylation. Plus...because there are 3 more indications ( particularly ASD, this is still a winner. Market over reaction has made this a very good buy ( if anyone has powder to spend now) . Curious about your thoughts.